IQVIA HOLDINGS INC. Increase (Decrease) in Other Operating Assets and Liabilities, Net
IQVIA HOLDINGS INC. (IQV) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $183.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-05-05
- IQVIA HOLDINGS INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-03-31 was $183.00M, a 47.58% increase year-over-year.
- IQVIA HOLDINGS INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-30 was -$106.00M.
- IQVIA HOLDINGS INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-06-30 was $245.00M, a 20.10% increase year-over-year.
- IQVIA HOLDINGS INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-03-31 was $124.00M, a 53.09% increase year-over-year.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month as first filed |
|---|---|---|---|---|---|---|
| 2026-03-31 | $183.00M 10-Q · filed 2026-05-05 | |||||
| 2025-09-30 | -$106.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $139.00M derived: sum of 2 quarters · filed 2025-10-28 | $263.00M 10-Q · filed 2025-10-28 | |||
| 2025-06-30 | $245.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $369.00M 10-Q · filed 2025-07-22 | ||||
| 2025-03-31 | $124.00M 10-Q · filed 2026-05-05 | |||||
| 2024-09-30 | -$79.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $125.00M derived: sum of 2 quarters · filed 2025-10-28 | $206.00M 10-Q · filed 2025-10-28 | |||
| 2024-06-30 | $204.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $285.00M 10-Q · filed 2025-07-22 | ||||
| 2024-03-31 | $81.00M 10-Q · filed 2025-05-06 | |||||
| 2023-09-30 | -$85.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $44.00M derived: sum of 2 quarters · filed 2024-10-31 | $112.00M 10-Q · filed 2024-10-31 | |||
| 2023-06-30 | $129.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-22 | $197.00M 10-Q · filed 2024-07-22 | ||||
| 2023-03-31 | $68.00M 10-Q · filed 2024-05-02 | |||||
| 2022-09-30 | -$223.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$174.00M derived: sum of 2 quarters · filed 2023-11-01 | -$9.00M 10-Q · filed 2023-11-01 | |||
| 2022-06-30 | $49.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $214.00M 10-Q · filed 2023-08-01 | ||||
| 2022-03-31 | $165.00M 10-Q · filed 2023-04-28 | |||||
| 2021-09-30 | -$53.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $101.00M derived: sum of 2 quarters · filed 2022-10-27 | $113.00M 10-Q · filed 2022-10-27 | |||
| 2021-06-30 | $154.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | $166.00M 10-Q · filed 2022-07-22 | ||||
| 2021-03-31 | $12.00M 10-Q · filed 2022-04-28 | |||||
| 2020-09-30 | -$53.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | $12.00M derived: sum of 2 quarters · filed 2021-10-22 | $137.00M 10-Q · filed 2021-10-22 | |||
| 2020-06-30 | $65.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $190.00M 10-Q · filed 2021-07-28 | ||||
| 2020-03-31 | $125.00M 10-Q · filed 2021-04-23 | |||||
| 2019-09-30 | -$128.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22 | -$150.00M derived: sum of 2 quarters · filed 2020-10-22 | $38.00M 10-Q · filed 2020-10-22 | |||
| 2019-06-30 | -$22.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | $166.00M 10-Q · filed 2020-07-23 | ||||
| 2019-03-31 | $188.00M 10-Q · filed 2020-04-30 | |||||
| 2018-09-30 | -$136.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | -$101.00M derived: sum of 2 quarters · filed 2019-11-01 | -$114.00M 10-Q · filed 2019-11-01 | |||
| 2018-06-30 | $35.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $22.00M 10-Q · filed 2019-07-24 | ||||
| 2018-03-31 | -$13.00M 10-Q · filed 2019-05-02 | |||||
| 2017-09-30 | -$29.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | -$36.00M derived: sum of 2 quarters · filed 2018-10-25 | $151.00M 10-Q · filed 2018-10-25 | |||
| 2017-06-30 | -$7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $180.00M 10-Q · filed 2018-07-27 | ||||
| 2017-03-31 | $187.00M 10-Q · filed 2018-05-04 | |||||
| 2016-09-30 | -$23.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | -$40.00M derived: sum of 2 quarters · filed 2017-10-27 | $30.00M 10-Q · filed 2017-10-27 | $30.84M 10-Q · filed 2016-11-03 | ||
| 2016-06-30 | -$17.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $53.00M 10-Q · filed 2017-08-04 | $53.23M 10-Q · filed 2016-07-27 | |||
| 2016-03-31 | $70.00M 10-Q · filed 2017-05-08 | $68.78M 10-Q · filed 2016-05-03 | ||||
| 2015-09-30 | -$108.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$163.11M derived: sum of 2 quarters · filed 2016-11-03 | -$45.10M 10-Q · filed 2016-11-03 | -$44.03M 10-Q · filed 2015-10-28 | ||
| 2015-06-30 | -$54.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | $63.02M 10-Q · filed 2016-07-27 | $63.03M 10-Q · filed 2015-07-29 | |||
| 2015-03-31 | $118.01M 10-Q · filed 2016-05-03 | $118.02M 10-Q · filed 2015-04-29 | ||||
| 2014-09-30 | -$78.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | -$37.02M derived: sum of 2 quarters · filed 2015-10-28 | $50.93M 10-Q · filed 2015-10-28 | |||
| 2014-06-30 | $41.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $129.65M 10-Q · filed 2015-07-29 | $129.39M 10-Q · filed 2014-07-31 | |||
| 2014-03-31 | $87.95M 10-Q · filed 2015-04-29 | $87.77M 10-Q · filed 2014-05-01 | ||||
| 2013-09-30 | -$25.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$77.42M derived: sum of 2 quarters · filed 2014-10-30 | -$3.13M 10-Q · filed 2014-10-30 | -$7.57M 10-Q · filed 2013-10-31 | ||
| 2013-06-30 | -$52.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $22.17M 10-Q · filed 2014-07-31 | $18.18M 10-Q · filed 2013-08-01 | |||
| 2013-03-31 | $74.29M 10-Q · filed 2014-05-01 | $74.30M 10-Q · filed 2013-05-14 | ||||
| 2012-09-30 | -$37.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | -$72.70M derived: sum of 2 quarters · filed 2013-10-31 | -$8.35M 10-Q · filed 2013-10-31 | |||
| 2012-06-30 | -$34.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $29.39M 10-Q · filed 2013-08-01 | ||||
| 2012-03-31 | $64.35M 10-Q · filed 2013-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |